Engineers Gate Manager LP

Position in RGNX — REGENXBIO Inc.

CIK 1620220 NEW YORK, NY

Position in RGNX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$412,112

-$121,694 QoQ

Shares Held

34,400

-46.0% QoQ

Ownership

0.052%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#77

of 164 holders

Holding Since

Sep 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Engineers Gate Manager LP holds $195,980,910 across 162 Biotechnology names. RGNX ranks #100 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	126,044	$13,438,811
2	BMRN	Biomarin Pharmaceutical Inc	181,647	$10,393,841
3	ALNY	Alnylam Pharmaceuticals, Inc.	33,469	$10,075,173
4	REGN	Regeneron Pharmaceuticals, Inc.	15,918	$9,925,509
5	RPRX	Royalty Pharma plc	137,994	$7,737,323
6	EXEL	Exelixis, Inc.	110,353	$6,004,306
7	ONC	BeOne Medicines Ltd.	16,302	$4,645,580
8	VERA	Vera Therapeutics, Inc.	108,139	$4,640,244

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$412,112	34,400	-46.0%	Shares	Sole	2026-08-14
2026-03-31	$533,806	63,700	+114.3%	Shares	Sole	2026-05-15
2025-09-30	$286,894	29,730	-42.6%	Shares	Sole	2025-11-14
2025-06-30	$425,384	51,813	+2.1%	Shares	Sole	2025-08-14
2025-03-31	$362,812	50,743	+11.1%	Shares	Sole	2025-05-15
2024-12-31	$353,175	45,689	+128.8%	Shares	Sole	2025-02-14
2024-06-30	$233,613	19,967	-21.7%	Shares	Sole	2024-08-14
2023-12-31	$457,850	25,507	+28.8%	Shares	Sole	2024-02-14
2021-12-31	$647,361	19,797	+1.6%	Shares	Sole	2022-02-14
2021-03-31	$664,326	19,476	+209.6%	Shares	Sole	2021-05-17
2020-12-31	$285,314	6,290	-49.4%	Shares	Sole	2021-02-16
2020-09-30	$341,963	12,426	—	Shares	Sole	2020-11-16
No filing history on record for this holder in this stock.